The morning after:What now for psychiatry research? by Wessely, Simon & Nicholson, Krista
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1186/s12916-016-0655-x
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Wessely, S., & Nicholson, K. (2016). The morning after: What now for psychiatry research?. BMC Medicine,
14(1), [105]. 10.1186/s12916-016-0655-x
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
EDITORIAL Open Access
The morning after: what now for psychiatry
research?
Simon Wessely1,2* and Krista Nicholson2
Abstract
The UK scientific community is rightly concerned about the impact of leaving the EU on UK science. These concerns
are particularly pertinent for mental health research, which is chronically underfunded in comparison to research on
physical health conditions. The EU is one of the largest funders of mental health research in the world, with the UK
clearly benefitting from this because of its strong track record. Any loss of funding, leadership or influence would
weaken this. Likewise if we are unable to attract the best or most promising researchers from the rest of Europe, the
loser will not just be research into mental health across Europe, but patients themselves. Those working on the Brexit
negotiations must develop clear and coherent plans to safeguard scientific research in UK and ensure that the
momentum gained in mental health policy in recent years is not lost.
Editorial
The future of UK science was not much of an issue during
the EU referendum campaign. This was probably because
most of the voters don’t think about science most of the
time. Furthermore, the Leave campaign, which seemed to
lead the debate, would have been foolish to push science
up the agenda. The UK’s science community, including all
those in health and medicine, overwhelmingly supported
remaining in the EU. The British Medical Journal was un-
able to “name one prominent national medical, research,
or health organization that has sided with Brexit” [1].
It is not hard to understand why. The UK has hugely
benefited from EU research funding, receiving €8.8 billion
between 2007-2013 despite only contributing €5.4 billion
to the EU research budget over the same period [2]. Under
the current Horizon 2020 research programme the UK
has won more projects than any other country [3], and
also leads on more collaborations than any other country.
Expressions of support to remain came from 5,500 UK
scientists [4], all the ex-Presidents of the Academy of
Medical Sciences [5], 71 ex-Presidents of the Medical
Royal Colleges [6], 13 Nobel Laureates [7] and 150 Fel-
lows of the Royal Society [8] and so on. If the vote had
been decided on expertise, it would have been very one
sided. But in what may turn out to be Michael Gove’s
only contribution to dictionaries of quotations, the
public seemed to have “had enough of experts”.
And now we have to deal with the consequences.
Sometimes after contested, emotion driven elections,
even when things don’t go the way one hoped, it doesn’t
seem so bad when the noise has died down. Not so for
science. Professor Sir Robert Lechler, President of the
Academy of Medical Sciences, has called the referendum
result “the most serious threat and challenge to UK re-
search in my lifetime” [9].
We are particularly concerned about the implications
for mental health research, which dispiritingly remains
chronically underfunded in comparison to research on
physical health conditions, despite similar returns on in-
vestment. In the UK we invest less than 6 % of the annual
health research budget on mental illness (£115 million),
[10] despite its accounting for around 23 % of the disease
burden [11]. In a sector where every penny counts, UK re-
searchers cannot afford to miss out on EU support.
The EU remains the largest single funder of mental
health research in Europe and indeed one of the 10 lar-
gest funders globally [12]. FP7, for example, invested
€1.92 billon in brain research between 2007 and 2012,
[13]. But it’s not just about money. Like all science, re-
search into psychiatry/neuroscience is a collaborative en-
terprise which benefits from people working together and
sharing ideas and resources, and the EU is at the heart of
that. At present there are several major collaborations led
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by UK scientists. NEWMEDS is a major initiative linking
eight universities and ten pharm/biotech companies ad-
dressing schizophrenia and depression [14]. Then we
have EU AIMS (autism treatment) [15], EU MATRICS
(aggression) [16], EU TACTICS (obsessive compulsive
disorder) [17], EU BRAINVIEW (training young scientists
in brain development) [18], MILESTONES (improving
transition between child and adult mental health series)
[19] and RADAR CNS, funded from IMI2, linking univer-
sities, five pharmaceutical and two software companies,
testing the utility of digital phenotyping to assess clinical
state and predict relapse in multiple sclerosis, epilepsy and
recurrent depression [20].
The importance of collaboration for the future of men-
tal health research across Europe was confirmed by the
2015 ROAMER (“Road Map for Mental Health Research
in Europe”) project, the largest ever exercise for setting
out ‘a comprehensive, coordinated mental health research
agenda for Europe’ and again UK led [21]. The ROAMER
recommendations have also been incorporated into the
NHS-England Five Year Forward View for Mental Health
[22].
With this in mind, there could not be a worse time for
UK researchers to be marginalised from mental health
research in the rest of Europe, and vice versa. The UK is
a powerhouse of mental health research, undertaking
more studies than any other country in Europe, with its
largest institution, the Institute of Psychiatry, Psychology
and Neuroscience, ranked first in the world according to
Thomson’s Essential Science Indicators. No one who
cares about mental health and neuroscience research, on
both sides of the Channel, will want to see UK science
isolated.
Science benefits from easy movement of labour. EU
freedom of movement regulations, which allow researchers
and clinicians to work in any member state, are one reason
that around one in six (16 %) of all academic staff at UK
Universities are non-UK EU nationals [23]. And it would
be hard to think of a UK research project that had not
benefited from the contributions of interns, PhD students
or research fellows from across the region.
But perhaps the biggest impact is the hardest to quan-
tify. This is the potential negative impact on our ability to
attract high quality researchers. As the House of Lords
Science and Technology Select Committee warned before
the vote, “researcher mobility must be protected if UK sci-
ence and research is to remain world-leading” [24].
So we currently face years of uncertainty around the
rights of EU nationals already in the UK and for those
looking to come here in the future, as well as uncer-
tainty around UK access to the ERASMUS scheme and
around the amount of fees EU students will pay to study
at UK universities. This is much more than simply the
right to remain; it involves all the benefits that come with
EU citizenship, including recognition of qualifications,
portability of pensions, access to health care and much
else. Anecdotal evidence is already accumulating that re-
searchers are being put off accepting jobs in the UK. We
need swift action to reassure that we are “open for
business”.
Likewise, we remain in the EU for at least two more
years, during which time UK scientists are still eligible
to apply under all EU science schemes, and any grants
awarded will be honoured for the duration of the award.
There is already confusion about this and evidence that
UK scientists are already being dropped from EU sci-
ence projects because of funding fears [25]. The grass
roots science campaign, “Scientists for the EU” are cur-
rently collecting data on all these issues to inform pol-
icy, negotiations and that existing rights remain
honoured – there is a website for recording these issues
as soon as they arise –(http://scientistsforeu.uk/moni-
toring-brexit-impact/).
One outcome would be that the Brexit negotiations re-
sult in the UK achieving “associated country” status,
similar to the Norwegian model, which would allow us
to “buy into” the EU science programme and apply for
Horizon 2020 projects in the same way as if we had
remained an EU member state. However, associated
country status is not guaranteed and a pre-condition for
participation will almost certainly be continued freedom
of movement between EU countries, which almost cer-
tainly seems unpalatable to those who support Leave. If
politicians decide the referendum is a mandate to limit
migration, we could suffer the same fate as Switzerland
following their 2014 referendum vote to limit mass mi-
gration. Initially suspended from Horizon 2020, they
have now been relegated to a “partially associated” status
and forced to increase national spending to try and
match the funds lost. By some estimates this has re-
duced their participation in EU research projects by
40 % [26].
Associated country status is no panacea and would be
a serious blow to the UK’s reputation as a heavyweight
in European science. We would no longer be able to par-
ticipate in negotiations over any future EU funding strat-
egies (which we have previously played a huge role in
shaping) [27] and we would also lose influence over
other EU policies, (such as the Clinical Trials and Data
Protection directives, both of which ended well, but only
because of our active lobbying and influence), which we
would either be forced to adopt or again risk remaining
out in the cold.
Despite this gloomy outlook, with the referendum be-
hind us, there is a now a clear agenda for all those who
believe science plays a vital role in improving our health
and wellbeing. Those of us who supported Remain must
do everything we can not to be proven right in the fears
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we expressed during the campaign. Those who sup-
ported Leave likewise now need to be clear how they will
make good on their promises for the NHS, and come up
with some clear and coherent plans to safeguard scien-
tific research, and do so without delay. We must ensure
that mental health is not forgotten in these negotiations,
and that the momentum of previous years of work is not
lost. Mental health research funding needs a significant
uplift and the UK must remain a key player in pushing
forward the ROAMER agenda in Europe.
One of the main leaders of the Leave campaign had a
good line in Shakespearean and classical allusions. So
continuing the theme, we note there is a tide in the affairs
of men, which if we don’t get right, means that re-
searchers, mental health professionals and patients across
Europe will wallow in the shallows while others are led on
the current to fortune.
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